Our hospital is beginning a sepsis clinical pathway. Up until now, we have been near 100% with our antibiotic selection choice for the community acquired pneumonia core measure. There is a great deal of institutional concern that we might begin failing this metric if we give broad spectrum antibiotics to our severe sepsis/septic shock patients and they are ultimately diagnosed with CAP. How are other institutions dealing with the conflicting imperatives?
-Andy __________________________ Andrew Markowski, M.D., M.P.H. Department of Emergency Medicine Suburban Hospital 214-766-0665 _______________________________________________ Sepsisgroups mailing list [email protected] http://lists.sepsisgroups.org/listinfo.cgi/sepsisgroups-sepsisgroups.org
